LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    VERAMARIS® – Transforming Aquaculture using Biotechnology

    09/10/2024

    CASE STUDY

    Submission from Evonik Operations GmbH and dsm-firmenich

    The innovation.

    The omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are essential for human and animal health. They are known to support many body functions, including heart health, brain development, the nervous system, and the immune system. As the human body does not naturally produce omega-3s, they must be obtained through diet or supplements. Oily fish, such as Atlantic salmon - primarily sourced from aquaculture - is an excellent source of both EPA and DHA. Even though EPA and DHA are equally important for fish health, they are not produced in sufficient quantities by the fish themselves and need to be supplemented in aquaculture feeds. Traditionally, the fatty acids added to aquaculture feed have come almost exclusively from marine sources such as fish oil and fishmeal from catches of wild fish, which is a finite resource.  

    In 2019, Veramaris introduced an alternative source of omega-3s from the natural marine microalgae Schizochytrium. The algal strain originates from the North Pacific. This microalgae has been brought to the industrial environment by an innovative approach in a state-of-the-art, world-scale facility in Blair (Nebraska, USA). In this plant, the marine protist is fermented under controlled conditions in large bioreactors, similar to a brewing process. The microalgae convert sugar, oxygen, and other nutrients into oil, rich in EPA and DHA, with high efficiency. The innovative and waste-free fermentation and oil separation processes allow the production of an oil which has the highest available concentration of both EPA and DHA on the market.

    The Veramaris process was developed by a joint biotechnology team, consisting of dozens of experts from different disciplines: biologists, engineers, technologists – from dsm-firmenich and Evonik Operations GmbH. The algal oil is separated from the algae cells by a solvent free process in a mild approach, which allows high isolation yields while ensuring the highest oil quality and stability. Since the tailor-made industrial fermentation process is waste-free, every ton leaving the plant can be used for nutritional purposes. The efficiency of the production process was improved significantly in the last years by a combination of improving the microalgae itself by natural selection and screening, as well as by continuous optimization of the fermentation and downstream process.

    The benefits.

    This biotech innovation helped to develop a product for Veramaris that is ideal for the growth of healthy animals as it fulfils the key criteria of feed safety, sustainability, nutritional value, and functionality:

    • It is the world’s first ASC-MSC-certified microalgae oil.
    • It provides access to the healthy omega-3 sources EPA and DHA, which are critical for animal welfare.
    • It has the highest concentration of EPA and DHA of comparable sources of omega-3 fatty acids and is up to four times more potent than fish oil.
    • Due to its oily nature, it is the ideal product formulation for the feed industry and can be applied 1:1 in modern feed formulations. Furthermore, it allows flexible adaption of diets for the purpose of different live stages of fish.
    • It promotes growth of a sustainable aquaculture industry without making higher demands on marine resources.
    • Veramaris is committed to the SBTi initiative and reduced scope 1 and 2 emissions by 27% between 2022 and 2024. It has now taken a step further and announced that it aims to reduce scope 3 greenhouse gases (scope 3 emissions) by 22.5% by 2030, compared to 2021

    All this will be driven forward by continued joint biotechnology support by Evonik Operations GmbH and dsm-firmenich.

    Additional materials:

    Carr et al., 2023. The importance of essential fatty acids and their ratios in aquafeeds to enhance salmonid production, welfare, and human health. Front. Anim. Sci., 16 May 2023, Sec. Animal Nutrition, Volume 4 – 2023, https://doi.org/10.3389/fanim.2023.1147081

    Santigosa et al, 2023. Algal oil gives control of long-chain omega-3 levels in full-cycle production of Atlantic salmon, without detriment to zootechnical performance and sensory characteristics. Journal of the World Aquaculture SocietyVolume 54, Issue 4 p. 861-881, https://doi.org/10.1111/jwas.12947

    Veramaris – Sustainability

    Veramaris – How It Is Made

    Veramaris – Optimum Omega Nutrition

     

     

    VERAMARIS® – Transforming Aquaculture using Biotechnology


    Download

    Share
    Communications Team
    Communications Team

    Related posts

    05/06/2026

    The Baker Company Benelux BV joins EuropaBio: Advancing cell culture and lab safety technologies


    Read more
    04/06/2026

    Bio-based and Biodegradable Industries Association (BBIA) joins EuropaBio: Supporting the bio-based economy


    Read more
    29/05/2026

    The Luxembourg Institute of Science and Technology joins EuropaBio: Advancing Applied Biotechnology in Europe


    Read more

    Important links

    • The Baker Company Benelux BV joins EuropaBio: Advancing cell culture and lab safety technologies
    • Bio-based and Biodegradable Industries Association (BBIA) joins EuropaBio: Supporting the bio-based economy

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.